Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer

NCT04110769 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT04110769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04110769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 17, 2019
Completion date
December 31, 2023
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, genetic change, pancreatic cancer